Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06836271Phase 2Not yet recruiting
Phase 2, randomised, open-label trial (4 arms), sponsored by Hitit University. Primary endpoints: Procedure-related infective complications at 14 days and Determination of sample size at 6 months. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06836271.